The dementia phase is by far the most challenging stage of Alzheimer's, and it poses the heaviest burden on caregivers. In this blog post, we will explore the dementia phase of Alzheimer's, what researchers are testing, and the future outlook for the disease.
Dementia is characterized by a profound decline in memory, cognition, and communication skills, making it impossible for those affected to function independently. In this setting, patients can develop psychiatric signs and symptoms such as agitation, paranoia, and hallucinations, impairing quality of life. The burden on caregivers is significant, as they must provide round-the-clock care, attend to their loved one's basic needs, and ensure their safety. By focusing on how we can improve the quality of life for those with dementia, we hope to not only help those affected by AD but also their caregivers and loved ones.
Researchers have been testing various approaches to alleviate symptoms and improve the quality of life for those with dementia. One such approach is non-pharmacological interventions, such as sensory stimulation, music therapy, and pet therapy. These interventions aim to soothe patients and decrease agitation and disruptive behavior. Pharmacological interventions, such as antipsychotics, antidepressants, and cholinesterase inhibitors, are also being tested to manage behavioral symptoms and improve cognitive function. The recently launched LiBBY study is currently testing the use of THC and CBD to reduce agitation for those at this stage of Alzheimer’s.
While a significant amount of research is focused on preventing individuals from reaching the dementia phase of Alzheimer's disease, that doesn’t mean that the research stops trying to help those who are already at this stage.
By managing symptoms and reducing the negative effects for those living with dementia, we can improve the quality of life of those dealing with this tragic disease. In addition, training programs for caregivers, respite care, and support groups are some of the interventions that have been shown to alleviate caregiver burden. Telemedicine and online support have also proven to be beneficial for caregivers who may not have access to in-person resources. We look to alleviate the largest burdens of this late stage of Alzheimer's by reducing the symptoms, improving the quality of life for those with dementia, and providing better resources and tools for the caregivers who support them.
Remember, there are no definitive cures for Alzheimer's disease and dementia, but early detection and intervention can significantly improve the quality of life for those living with dementia and their loved ones. By educating oneself about the disease and supporting those affected by it, we can create a more informed and compassionate society that is better equipped to help those affected by Alzheimer's disease. Those interested can consult their primary healthcare providers, reach out to ATRI, or search for ongoing trials in their area.